CJ Healthcare launches "Atomet's slowdown"



[ad_1]

Association of atorvastatin for the treatment of dyslipidemia and metformin for the treatment of diabetes

Simultaneous treatment of dyslipidemia and diabetes mellitus as a single drug Payable from 1 August [19659003] CJ Healthcare

CJ Healthcare (CEO Kang Seok-hee and Yoon Sang-hyun) announced that they have developed a combination of "Atomet Slowan" (Atomet), which simultaneously treats dyslipidemia and diabetes, [19659005] Atomet is a combination of "atorvastatin", a drug to treat dyslipidemia, and "metformin", a type 2 diabetes drug, and metformin and atorvastatin must be administered simultaneously.

This year, the Korean Diabetes Association received the national survey on health and nutrition In particular, an badysis of data from the 2013 National Health and Nutrition Survey to 2016 showed that one in three diabetic patients aged 30 or older was accompanied by hypercholesterolemia.

In clinical trials, Atomat reported that atorvastatin compared to the single-dose group of metformin, the effectiveness of lowering LDL-C and hypoglycemic effects was comparable.

CJ Healthcare stated: "Atomet is able to treat dyslipidemia, which is badociated with type 2 diabetes mellitus, in combination with diabetes mellitus, in comparison with atorvastatin and metformin." At the symposium national for health professionals, we plan to actively promote the trend of prescribing a combination of dyslipidemia and diabetes mellitus. "

Atorvastatin, metformin combination of Ato Met Sajangjeong is a total of 4 contents including 10 / 500mg (743 won per one), 10 / 750mg (733 won per one), 20 / 500mg (745 won per one) and 20 / 750mg Diabetes Information Sheet [201459003] Fact Sheet on Diabetes [201459003] Diabetes Diagnostic Criteria Among Diabetes Information Sheet 2018: ① If your doctor has diagnosed you with diabetes ② If you are taking oral medication Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia, Hypertroph iglyceridaemia, hypertriglyceridaemia, hypertriglyceridaemia, hypertriglyceridaemia, hypertriglyceridaemia, hypertriglyceridaemia, hypertriglyceridaemia, hypertriglyceridaemia, hypertriglyceridaemia, The term "dyslipidemia" refers to a wide range of diseases including all three disorders. (19459003) ▶ Hyperlipidemia : Hyperlipidemia is a condition in which many fatty substances accumulate on the wall of blood vessels more than necessary and cause inflammation leading to cardiovascular disease. When a small part of the blood vessel is narrowed by mild arteriosclerosis, there is no symptom, but when the complication develops, the vein is blocked and the hemiparesis is caused by stroke, the artery of the leg is blocked and peripheral arterial occlusion is acquired. Life is dangerous if it is blocked. (19659004) ▶ Prevalence of hypercholesterolemia : Percentage of total cholesterol in the blood exceeding 240 mg / dL or cholesterol-lowering (%) (Source: National Survey of Health Status and Health) nutrition) 19659014] [ad_2]
Source link